A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma
Clinical trial NCT04833582 · COMPLETED
Trial details
- NCT number
- NCT04833582
- Sponsor
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2023-08-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.